denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Special-Interest Sessions
Sunday, December 10, 2023: 11:15 AM-12:15 PM
Room 24
(San Diego Convention Center)
Panelists:
Catherine M. Bollard, MD, Children’s National Hospital
and
Andrew S. Weyrich, PhD, Oklahoma Medical Research Foundation
Disclosures:
Bollard: Roche: Consultancy; Cabaletta Bio, Catamaran Bio: Current equity holder in private company, Current equity holder in publicly-traded company, Current holder of stock options in a privately-held company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties: Patent applications in CAR-NKs.
The Blood Advances Editor-in-Chief Dr. Catherine Bollard and Deputy Editor Dr. Andrew Weyrich will lead a panel discussion on How to Peer Review a Scientific Paper. The session will provide valuable information on the best practices of peer review from the editorial perspective for both basic and clinically relevant manuscripts. There are multiple professional benefits to becoming a reviewer. It allows the hematologist to stay current on research and developments in the field and can help in patient care, in the lab, and in the classroom. It also has the additional benefits of allowing the reviewer to be recognized by their colleagues, and the reviewer can use the experience to demonstrate professional development with their institution.
See more of: Special-Interest Sessions